McKesson Corp (MCK) Enterprise Value to EBITDA (EV/EBITDA): 14.85

Since March 31st, 2010, McKesson Corp's enterprise value to ebitda (ev/ebitda) has increased from 5.68 to 14.85 at September 12th, 2024.

From 2010 to 2024 McKesson Corp's highest enterprise value to ebitda (ev/ebitda) was 72.09
McKesson Corp's lowest enterprise value to ebitda (ev/ebitda) during that period was 3.79
McKesson Corp's average enterprise value to ebitda (ev/ebitda) from 2010 to 2024 McKesson Corp's was 13.64

McKesson Corp's enterprise value to ebitda (ev/ebitda) as of September 12th, 2024 of 14.85 was lower than its peers in the Drugs Wholesale industry group of August 31st, 2024 of 33.53. From March 31st, 2010 to September 12th, 2024, McKesson Corp's average enterprise value to ebitda (ev/ebitda) was 13.64 compared to an industry average of 24.54.

About McKesson Corp

McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells financial, operational and clinical solutions for pharmacies. The McKesson Technology Solutions segment provides software, automation, business services and consulting to hospitals, physician offices, imaging centers and home healthcare. It also provides interactive connectivity services that streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies and financial institutions agencies and payers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Wilmington, DE.